Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Emerging Oncology Drugs in Pharma R&D Pipeline

Posted on March 2nd, 2017 by in Pharma R&D

Cancer. It’s the 2nd leading cause of death in this country (1), and a disease feared by patients and healthcare professionals alike. Today’s cancer treatments vary in nature, and also, efficacy and levels of side effect profiles. Continue reading “Emerging Oncology Drugs in Pharma R&D Pipeline” »

How Bioinformatics is Boosting Precision Medicine

Posted on January 9th, 2017 by in Pharma R&D

Although the pharmaceutical industry has invested a great deal in data-producing technologies (e.g. next-generation and single cell sequencing), it has been slower to invest in the data management and analytics technologies Continue reading “How Bioinformatics is Boosting Precision Medicine” »

Elsevier and the Cancer Moonshot

Posted on August 17th, 2016 by in Pharma R&D

R_D_Solutions_Blog_Needle_DIGITAL

“Last year, Vice President Biden said that with a new moonshot, America can cure cancer. Last month, he worked with this Congress to give scientists at the National Institutes of Health the strongest resources that they’ve had in over a decade. So tonight, I’m announcing a new national effort to get it done,” said President Obama in his final State of the Union address in January 2016.

Continue reading “Elsevier and the Cancer Moonshot” »

Review of Alzheimer’s Association International Conference (AAIC16) Part 1: Focus on Tau

Posted on August 10th, 2016 by in Pharma R&D

I have just returned from the Alzheimer’s Association International Conference (AAIC16) in Toronto, Canada. Toronto is a beautiful cosmopolitan city and a perfect setting for scientists from across the globe to come and share their latest research on Alzheimer’s disease. Continue reading “Review of Alzheimer’s Association International Conference (AAIC16) Part 1: Focus on Tau” »